Informed Consent for Hysterectomy

Section 1info grid
Section 2text block
Section 3text block
Section 4list block
Section 5text block
Section 6list block
Section 7text block
Section 8text block
Section 9text block
Section 10text block
Section 11text block
Section 12text block
Section 13signature block

Informed Consent for Hysterectomy

Patient and Surgical Information

Nature and Purpose of the Procedure

Hysterectomy is the surgical removal of the uterus. It is the most definitive treatment for several benign gynecological conditions and is required for gynecological cancers. The specific type and approach are determined by the indication, uterine size, prior surgeries, and patient anatomy. Total hysterectomy removes the uterus and cervix; subtotal (supracervical) hysterectomy removes the uterus body only, leaving the cervix in place (cervical cancer screening must continue). Radical hysterectomy removes the uterus, cervix, upper vagina, and parametrial tissues and is performed for cervical cancer. The procedure may be performed abdominally through a midline or Pfannenstiel incision, vaginally (no abdominal incision), laparoscopically (small keyhole incisions with camera and instruments), or using robotic assistance. Simultaneous bilateral salpingo-oophorectomy (removal of both fallopian tubes and ovaries) may be performed, which will cause immediate surgical menopause if you have not already undergone natural menopause.

Ovarian Conservation vs. Removal Decision

The decision to remove or preserve the ovaries (oophorectomy) is an important one with lifelong implications. Bilateral oophorectomy in premenopausal women causes immediate surgical menopause, with abrupt onset of hot flushes, night sweats, vaginal dryness, mood changes, sexual dysfunction, bone density loss (increased osteoporosis risk), and an increased long-term cardiovascular risk. Hormone replacement therapy (HRT) is strongly recommended in most women who undergo oophorectomy before the natural age of menopause (50 to 51) to mitigate these effects. Ovarian preservation avoids surgical menopause but retains a small lifetime risk of developing ovarian cancer (approximately 1.5 to 2 percent in the general population). In women with BRCA1 or BRCA2 mutations, the lifetime ovarian cancer risk is substantially higher (40 to 44 percent for BRCA1 carriers) and bilateral salpingo-oophorectomy is typically strongly recommended.

Material Risks and Potential Complications

Hemorrhage and blood transfusion: significant intraoperative or postoperative bleeding requiring transfusion occurs in approximately 1 to 2 percent of hysterectomies. Cell salvage and transfusion protocols will be in place.
Urinary tract injury: the bladder and ureters are in close proximity to the cervix and uterine vessels. Bladder injury occurs in 0.5 to 1 percent; ureteral injury in 0.1 to 0.5 percent. Both are more common in repeat surgery or in the presence of pelvic adhesions.
Bowel injury: inadvertent enterotomy, particularly in the presence of endometriosis-related adhesions. Requires intraoperative or delayed surgical repair.
Conversion to open surgery: laparoscopic or vaginal procedures may need to be converted to open abdominal surgery if visualization is inadequate, bleeding occurs, or unexpected findings are identified. Conversion rate is approximately 5 to 10 percent in complex cases.
Surgical site infection: wound infection or pelvic cellulitis in 5 to 10 percent; vault granulation tissue in up to 30 percent of vaginal vault closures; usually managed conservatively with antibiotics.
Venous thromboembolism: increased DVT risk following pelvic surgery; prophylactic LMWH and compression stockings are used.
Pelvic floor dysfunction: vault prolapse or alteration in bladder function may occur following hysterectomy, particularly if pelvic floor support structures are disrupted.
Permanent loss of fertility: hysterectomy results in permanent inability to carry a pregnancy. If you wish to preserve fertility, this must be discussed with your surgeon, as alternative treatments may be appropriate for benign conditions.

Fertility Implications

Hysterectomy results in permanent inability to carry a pregnancy. This surgery is irreversible. If you may wish to have children in the future and if your condition is benign, your surgeon must discuss alternative uterus-preserving treatments with you (e.g. uterine artery embolization, myomectomy for fibroids; endometrial ablation for bleeding) before you consent to hysterectomy. If you have already completed your family or your condition is malignant, hysterectomy may be the most appropriate treatment.

Alternatives to Hysterectomy

For uterine fibroids: uterine artery embolization (UAE), myomectomy (removal of fibroids only), MRI-guided focused ultrasound (MRgFUS), or medical management (GnRH analogues, progesterone IUD, tranexamic acid).
For abnormal uterine bleeding: hormonal therapies (progesterone IUD, combined oral contraceptive pill, norethisterone), endometrial ablation, or expectant management near menopause.
For uterine prolapse: pelvic floor physiotherapy, vaginal pessary, or uterine suspension procedures.

Expected Benefits

Hysterectomy provides definitive cure for symptomatic uterine conditions including fibroids, adenomyosis, and abnormal uterine bleeding. Resolution of heavy menstrual bleeding, pelvic pain, and pressure symptoms is achieved in the majority of patients. For malignant indications, hysterectomy is a core component of curative surgical staging and treatment. Most patients report substantial improvement in quality of life following recovery.

Right to Refuse or Withdraw Consent

You have the right to refuse this procedure or withdraw your consent at any time before the procedure begins. For benign conditions, alternative management will be discussed. For malignant indications, declining surgery may have serious oncological consequences, which your surgeon will discuss with you.

Questions and Understanding Confirmation

I confirm that I have been counseled on the permanent loss of fertility resulting from this procedure and on the implications of bilateral oophorectomy if planned. All my questions have been answered to my satisfaction. I understand this is an irreversible procedure.

Language Access and Interpreter Services

If English is not your primary language or if you require assistance communicating, a qualified medical interpreter is available at no cost. Please notify your care team before signing this document.

Copy of Consent Acknowledgment

I acknowledge that I have been offered a signed copy of this informed consent form for my own records.

Patient Authorization

I have been informed of the hysterectomy procedure, its expected benefits, the material risks including the permanent loss of fertility, the implications of oophorectomy, and the available alternatives. I consent to proceed with hysterectomy as planned and authorize the surgeon to perform any additional procedures necessary for patient safety and adequate treatment.

Signatures and Verification

Patient Signature
Surgeon Signature
Witness Signature
Date and Time
Document ID: CC-PENDING
CONSENTCOLLECT